RecruitingNot ApplicableNCT04595422

Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines


Sponsor

M.D. Anderson Cancer Center

Enrollment

800 participants

Start Date

Jul 2, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This implementation study will examine the best ways to refer heavy smokers to information about lung cancer screening.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether training staff at smoking cessation phone lines (quitlines) can help educate smokers who call for help about lung cancer screening. The goal is to see if quitline callers — who are often at high risk for lung cancer — can be informed about and connected to screening programs. **You may be eligible if...** - You are a quitline staff member (for the training portion of the study) - OR you are a smoker who contacts a quitline and are between 55–80 years old - You are a current smoker or quit less than 15 years ago - You have smoked at least 30 pack-years (e.g., 1 pack/day for 30 years) - You speak English **You may NOT be eligible if...** - You (as a caller) have a previous history of lung cancer - You are under 55 or over 80 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREducational Intervention

Undergo training consisting of a 60-minute educational session

OTHEREducational Intervention

Receive lung cancer screening educational materials

OTHERQuestionnaire Administration

Complete questionnaire

OTHERSurvey Administration

Ancillary studies


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04595422


Related Trials